Our results are consistent with those described in pediatric patients with Hodgkin lymphoma in which immunohistochemistry analysis showed that those with high density of LAG-3 expression in tumor-infiltrating lymphocytes tended to have better event-free survival compared to patients with lower expression [38]. This evidence concerns the gene LAG3 and neoplasm.